MIRA
Income statement / Annual
Last year (2023), MIRA Pharmaceuticals, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, MIRA Pharmaceuticals, Inc.'s net income was -$11.98 M.
See MIRA Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$8.53 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$8.53 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$1.57 M
|
$2.35 M
|
$684,447.00
|
$14,647.00
|
| General & Administrative
Expenses |
$6.50 M
|
$2.99 M
|
$770,115.00
|
$158,946.00
|
| Selling & Marketing
Expenses |
$453,550.00
|
$0.00
|
$0.00
|
$52,823.00
|
| Selling, General &
Administrative Expenses |
$6.95 M
|
$2.99 M
|
$770,115.00
|
$52,982.00
|
| Other Expenses |
$0.00 |
-$1.70 M |
-$697,600.00 |
$0.00 |
| Operating Expenses |
$8.53 M |
$7.05 M |
$2.15 M |
$67,629.00 |
| Cost And Expenses |
$8.53 M |
$7.05 M |
$2.15 M |
$67,629.00 |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$3.46 M |
$10,250.00 |
$24,374.00 |
$364.00 |
| Depreciation &
Amortization |
$8.53 M
|
$7.05 M
|
$2.15 M
|
$202,887.00
|
| EBITDA |
$0.00
|
-$7.05 M
|
-$2.15 M
|
$0.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$3.46 M
|
-$10,250.00
|
-$24,374.00
|
$134,894.00
|
| Income Before Tax |
-$11.98 M |
-$7.06 M |
-$2.18 M |
-$67,993.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$7,047.94 |
-$2,152.16 |
-$202.89 |
| Net Income |
-$11.98 M |
-$7.06 M |
-$2.18 M |
-$67,993.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
| EPS |
-0.65 |
-0.48 |
-0.15 |
-0.0046 |
| EPS Diluted |
-0.65 |
-0.48 |
-0.15 |
-0.0046 |
| Weighted Average Shares
Out |
$18.57 M
|
$14.75 M
|
$14.75 M
|
$14.75 M
|
| Weighted Average Shares
Out Diluted |
$18.57 M
|
$14.75 M
|
$14.75 M
|
$14.75 M
|
| Link |
|
|
|
|
